Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider...
Read More
Katie Rose (Market Access Consultant) tells is about her experiences and activities in her first few weeks with us.
Working with a dedicated market access and health economics and outcomes research (HEOR) consultancy offers significant added value to Pharma and Medical Device companies and can give you the confidence...
Read More
Client Services Manager Parishee Desai tells us about her role supporting client partnerships and her experiences in her first year with Mtech Access.
The NHS Confederation has published a report exploring health economics in the NHS, with contributions from a range of leaders and innovators, including our own Prof Phil Richardson.
Araadhna Sinha tells us about her research evaluating NICE’s new disease severity modifier. Including the impact it could have had on past Health Technology Assessments.
We sit down with Heather Wellam (Senior Consultant – Market Access) to learn more about her work managing global market access, pricing and strategy projects. Heather shares how her work involves helping Pharma and Medtech companies to navigate complex and evolving healthcare systems to achieve market access.
Edyta Ryczek tells us about her research into the inclusion of Carer Health-Related Quality of Life measures in NICE Appraisals
Elizabeth Thurgar tells us about her ISPOR poster reviewing fast-track appraisals at NICE and the evolution of cost comparison
The proposed new NHS England (NHSE) systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects of policy...
Read More
